Literature DB >> 15781624

Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.

Silvia M Sirchia1, Lisetta Ramoscelli, Francesca R Grati, Floriana Barbera, Danila Coradini, Franca Rossella, Giovanni Porta, Elena Lesma, Anna Ruggeri, Paolo Radice, Giuseppe Simoni, Monica Miozzo.   

Abstract

In females, X chromosome inactivation (XCI) begins with the expression of the XIST gene from the X chromosome destined to be inactivated (Xi) and the coating of XIST RNA in cis. It has recently been reported that this process is supported by the product of the BRCA1 tumor suppressor gene and that BRCA1-/- cancers show Xi chromatin structure defects, thus suggesting a role of XCI perturbation in BRCA1-mediated tumorigenesis. Using a combined genetic and epigenetic approach, we verified the occurrence of XCI in BRCA1-/- and BRCA1wt breast cancer cell lines. It was ascertained that the Xi was lost in all cancer cell lines, irrespective of the BRCA1 status and that more than one active X (Xa) was present. In addition, no epigenetic silencing of genes normally subjected to XCI was observed. We also evaluated XIST expression and found that XIST may be occasionally transcribed also from Xa. Moreover, in one of the BRCA1wt cell line the restoring of XIST expression using a histone deacetylase inhibitor, did not lead to XCI. To verify these findings in primary tumors, chromosome X behavior was investigated in a few BRCA1-associated and BRCA1-not associated primary noncultured breast carcinomas and the results mirrored those obtained in cancer cell lines. Our findings indicate that the lack of XCI may be a frequent phenomenon in breast tumorigenesis, which occurs independently of BRCA1 status and XIST expression and is due to the loss of Xi and replication of Xa and not to the reactivation of the native Xi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781624     DOI: 10.1158/0008-5472.CAN-04-3465

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

Review 2.  FOXP3 as an X-linked tumor suppressor.

Authors:  Lizhong Wang; Runhua Liu; Mark Ribick; Pan Zheng; Yang Liu
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

3.  X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells.

Authors:  Susana S Silva; Rebecca K Rowntree; Shila Mekhoubad; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

4.  The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing.

Authors:  Matthew J Gamble; Kristine M Frizzell; Christine Yang; Raga Krishnakumar; W Lee Kraus
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

5.  Juxtaposition of heterochromatic and euchromatic regions by chromosomal translocation mediates a heterochromatic long-range position effect associated with a severe neurological phenotype.

Authors:  Palma Finelli; Silvia Maria Sirchia; Maura Masciadri; Milena Crippa; Maria Paola Recalcati; Daniela Rusconi; Daniela Giardino; Laura Monti; Francesca Cogliati; Francesca Faravelli; Federica Natacci; Leonardo Zoccante; Bernardo Dalla Bernardina; Silvia Russo; Lidia Larizza
Journal:  Mol Cytogenet       Date:  2012-04-04       Impact factor: 2.009

6.  Uncoupling of X-linked gene silencing from XIST binding by DICER1 and chromatin modulation on human inactive X chromosome.

Authors:  Satya Keerthi Kota; Debabani Roy Chowdhury; Lakshmi K Rao; Venkata Padmalatha; Lalji Singh; Utpal Bhadra
Journal:  Chromosoma       Date:  2014-11-27       Impact factor: 4.316

7.  The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells.

Authors:  Elena Lesma; Silvia Maria Sirchia; Silvia Ancona; Stephana Carelli; Silvano Bosari; Filippo Ghelma; Emanuele Montanari; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

Review 8.  Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Authors:  Deepti Sharma; George Koshy; Shruti Gupta; Bhushan Sharma; Sonal Grover
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

Review 9.  Guided by RNAs: X-inactivation as a model for lncRNA function.

Authors:  John E Froberg; Lin Yang; Jeannie T Lee
Journal:  J Mol Biol       Date:  2013-06-28       Impact factor: 5.469

10.  Misbehaviour of XIST RNA in breast cancer cells.

Authors:  Silvia M Sirchia; Silvia Tabano; Laura Monti; Maria P Recalcati; Manuela Gariboldi; Francesca R Grati; Giovanni Porta; Palma Finelli; Paolo Radice; Monica Miozzo
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.